• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    C

    Center for Infectious Disease Research and Policy

    cidrap.umn.edu
    58论文总数
    5,845引用总数

    The Center for Infectious Disease Research and Policy (CIDRAP) is a center within the University of Minnesota that focuses on addressing public health preparedness and emerging infectious disease response. It was founded in 2001 by Dr. Michael Osterholm, in order to "prevent illness and death from infectious diseases through epidemiological research and rapid translation of scientific information into real-world practical applications and solutions".It is not part of the Center for Disease Control or National Institute of Health.

    论文量&引用量时间轴

    机构学者

    论文(58)

    年份
    起
    –
    止
    排序
    1A Clinical Case of Disseminated BCG Infection with a Fatal Outcome
    S. M. Kharit,Yu. E. Konstantinova,V. E. Karev,I. A. Karabak,A. I. Konev,K. K. Tikhomirova, M. E. Lozovskaja

    Complications after the introduction of the tuberculosis vaccine develop extremely rarely. They become accidentally vaccinated infants with undiagnosed severe immunodeficiency. The article considers a clinical case of the course of disseminated BCG infection with multiple organ damage in congenital immunodeficiency in a 9-month-old boy. The disease manifested itself acutely, the child’s condition worsened within a week, and its outcome was the death of the baby. Primary immunodeficiency was confirmed by the results of a pathoanatomic examination. The discussion provides a classification of complications after the introduction of BCG vaccine, the algorithm of the doctor’s actions in case of a suspected complication after vaccination, and also describes the main signs of immunodeficiency.

    2024Journal Infectology(2024)
    引用
    AI阅读
    加入学术空间
    2Innovations in the Treatment and Prevention of Influenza in Children and Adolescents
    Yu. V. Lobzin, A. V. Gorelov, K. V. Zhdanov, D. A. Lioznov,I. V. Babachenko, A. S. Dmitriev,E. A. Dondurey,V. V. Krasnov,L. N. Mazankova,A. P. Prodeus, A. Yu. Rtishсhev,S. V. Rychkova,

    In September 2024, an Expert Council via videoconference was held to discuss innovative approaches to the tactics of diagnosis and therapy of influenza in children and adolescents in Russian Federation.Influenza is characterized by high morbidity and mortality, leading to 28,000 deaths annually worldwide among children.Influenza causes significant economic damage, ranking 4th among all infectious diseases in 2023 in Russian Federation. During the 2022­2023 period, there was an increase in influenza incidence with a traditionally high rate of infection among children. Newborns, children under 5 years old, and children with comorbidities are at high risk for complications. An analysis of influenza mortality shows that comorbidity is an aggravating factor in almost half of the cases.Timely diagnosis and etiotropic therapy are key in the treatment of influenza. The focus should be on etiological confirmation of the diagnosis within the first 24 hours from disease manifestation to prescribe specific antiviral therapy. Although laboratory confirmation of the diagnosis is recommended, during periods of high incidence, the diagnosis can be made based on clinical and epidemiological data. For final verification of the “influenza” diagnosis, the widespread use of certified rapid tests is proposed.According to the updated WHO guidelines published in September 2024, two medicines are recommended for the treatment of influenza — baloxavir and oseltamivir. Baloxavir marboxil significantly reduces the virus shedding time and has a favorable safety profile for children and adolescents. This makes it the medicine of choice, especially in cases of high risk of complicated influenza infection.Given the high importance of influenza in the structure of childhood morbidity, it is crucial to continue improving methods of prevention, diagnosis, and treatment of this disease, especially in children.

    2024Журнал инфектологии(2024)
    引用
    AI阅读
    加入学术空间
    3Meningococcal Infection in Children in the Period 2012–2021. Main Results of a Retrospective Multicenter Study, Issues of the Day
    A. A. Vilnits,Yu. V. Lobzin,N. V. Skripchenko,L. N. Mazankova,O. I. Klimova,A. Yu. Rtishchev,I. M. Osmanov,K. V. Markova,N. H. Tkhakushinova, G. P. Martinova,A. U. Sabitov, R. K. Babik,

    The heavy burden of meningococcal infection is associated not only with life-threatening complications in the acute period and high mortality in invasive forms of the disease, but also with severe consequences in survivors, who are not recorded in our country.The aim of study: to analyze clinical manifestations, complications of the acute period and outcomes of invasive forms of meningococcal disease in children in various regions of the Russian Federation.Materials and methods: an analysis of data from 1327 inpatient medical records of children with an invasive meningococcal infection from 14 regional centers of the Russian Federation for 2012-2021 was carried out (28.3% of cases of the disease in children in the represented federal districts).Results: it was found that young children predominated among the patients – the median was 27.4 (10.7-70.4) months. Complications of the acute period, often combined, were observed in 47.6% of cases. The development of septic shock was noted in 30.4%, Waterhouse-Friderichsen syndrome in 6.6%, carditis in 2.9%, cerebral edema in 15.7%, arthritis in 1.4% of cases; the formation of hydrocephalus, subdural effusion, sensorineural hearing loss in 1.8%, 0.6%, 1% of children, respectively. The presence of soft tissue necrosis requiring surgical intervention was noted in 3.5% of cases. Mortality rate was 10.1%. At the time of discharge from the hospital, 30% of children had complications associated with meningococcal infection: organ dysfunction/ failure in 13.2% of patients (severe in 1.3%), cerebral insufficiency in 19.6%; severe psycho-neurological deficits, sensorineural hearing loss, problems associated with the need for orthopedic/surgical interventions accounted for 0.7%, 0.6% and 0.8%, respectively.Conclusion. Considering the epidemiological features of meningococcal infection – the risk of a sharp increase in morbidity in short periods of time, the life-threatening nature of the disease itself, it is necessary to remain alert to these risks and take all possible measures to prevent the disease using all available means, the most effective of which is vaccine prevention.

    2024Journal Infectology(2024)
    引用
    AI阅读
    加入学术空间
    4Follow-up Assessment of Visceral Leishmaniasis Treated Patients and the Impact of COVID-19 on Control Services in Nepal.
    Anand Ballabh Joshi,Megha Raj Banjara,Murari Lal Das, Nav Raj Bist, Krishna Raj Pant,Uttam Raj Pyakurel,Gokarna Dahal,Krishna Prasad Paudel,Chuman Lal Das,Axel Kroeger,Abraham Aseffa

    Abstract Background Follow-up assessment of visceral leishmaniasis (VL) treated cases is important to monitor the long term effectiveness of treatment regimens. The main objective of this study was to identify the gaps and challenges in the follow-up of treated VL cases, to monitor treatment outcome and to assess the impact of COVID-19 on VL elimination services and activities. Methods Clinicians treating VL patients, district focal persons for VL, and patients treated for VL in seven high endemic districts in Nepal during 2019–2022 were interviewed to collect data on challenges in the follow-up of VL treated patients as per national strategy. Results Follow up status was poor in two districts with the largest number of reported cases. The majority of cases were children under 10 years of age (44.2%). Among 104 VL treated cases interviewed, 60.6% mentioned that clinicians had called them for follow-up but only 37.5% had complied. Among 112 VL treated cases followed up, 8 (7.14%) had relapse and 2 (1.8%) had PKDL. Among 66 cases who had VL during the COVID-19 lock down period, 32 (48.5%) were diagnosed within 1 week; however, 10 (15.1%) were diagnosed only after 4 weeks or more. During the COVID-19 pandemic, there was no active search for VL because of budget constraints and lack of diagnostic tests, and no insecticide spraying was done. Conclusion Relapses and PKDL are challenges for VL elimination and a matter of concern. Successful implementation of the national strategy for follow up of treated VL cases requires addressing elements related to patients (awareness, transport, communication) clinicians (compliance) and organization of service delivery (local health worker training and deployment). COVID-19 did not have much impact on VL diagnosis and treatment; however, public health programmes including active case detection and insecticide spraying for vector control were severely reduced.

    2023Tropical Medicine and Health(2023)引用:1
    引用
    AI阅读
    加入学术空间
    5The Clinical Case of a Combined New Coronavirus Infection and Whooping Cough in an Unvaccinated Child
    Yu. E. Konstantinova,I. V. Babachenko,S. M. Kharit,E. I. Bobova, M. Ya. Ioffe

    Whooping cough remains a life-threatening infection, especially for unvaccinated young children. The article describes a case of severe and non-smooth course of whooping cough in an unvaccinated girl of 4 months of life from the family hearth of whooping cough and COVID-19. There were cases of COVID-19 and whooping cough in adults in the family, occurring under the mask of a mild respiratory infection, not verified before they were detected in a child and did not require hospitalization. The combined course of two infectious diseases COVID-19 and whooping cough in a 4-monthold unvaccinated girl contributed to the prolongation of the duration of whooping cough, prolonged release of SARS-COV-2 RNA, the late appearance of hematological changes typical of whooping cough, the development of respiratory delays and re-hospitalization of a patient with prolonged respiratory support. In the context of the COVID-19 pandemic, the coverage of routine vaccination has significantly decreased, as a result of which children of the first years of life have become more vulnerable to vaccine-controlled infections, which causes the risk of combined infections.

    2023Journal Infectology(2023)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 58 篇论文

    合作机构(50)

    Minnesota Department of Health合作论文 10
    Saint Petersburg State Pediatric Medical University合作论文 6
    美国卫生与公众服务部合作论文 5
    明尼苏达大学合作论文 5
    乌得勒支大学合作论文 3
    Russian National Research Medical University合作论文 2
    卫生与环境科学研究所合作论文 2
    荷兰国家公共卫生与环境研究所合作论文 2
    Privolzhsky Research Medical University合作论文 2
    鹿特丹伊拉斯姆斯大学合作论文 1

    机构统计